Chronic Subdural Hematoma Treatment With Intra-Arterial Bevacizumab Injection
NCT06510582
·
clinicaltrials.gov ↗
PHASE1,PHASE2
Phase
RECRUITING
Status
140
Enrollment
OTHER
Sponsor class
Conditions
Chronic Subdural Hematoma
Interventions
DRUG:
Bevacizumab 2 mg/kg
DRUG:
Bevacizumab 4 mg/kg
Sponsor
The Cooper Health System
Collaborators
[object Object]